» Articles » PMID: 19411257

A New Sialidase Mechanism: Bacteriophage K1F Endo-sialidase is an Inverting Glycosidase

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2009 May 5
PMID 19411257
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Bacteriophages specific for Escherichia coli K1 express a tailspike protein that degrades the polysialic acid coat of E. coli K1 that is essential for bacteriophage infection. This enzyme is specific for polysialic acid and is a member of a family of endo-sialidases. This family is unusual because all other previously reported sialidases outside of this family are exo- or trans-sialidases. The recently determined structure of an endo-sialidase derived from bacteriophage K1F (endoNF) revealed an active site that lacks a number of the residues that are conserved in other sialidases, implying a new, endo-sialidase-specific catalytic mechanism. Using synthetic trifluoromethylumbelliferyl oligosialoside substrates, kinetic parameters for hydrolysis at a single cleavage site were determined. Measurement of kcat/Km at a series of pH values revealed a dependence on a single protonated group of pKa 5. Mutation of a putative active site acidic residue, E581A, resulted in complete loss of sialidase activity. Direct 1H NMR analysis of the hydrolysis of trifluoromethylumbelliferyl sialotrioside revealed that endoNF is an inverting sialidase. All other wild type sialidases previously reported are retaining glycosidases, implying a new mechanism of sialidase action specific to this family of endo-sialidases.

Citing Articles

Targeting Pseudomonas aeruginosa biofilm with an evolutionary trained bacteriophage cocktail exploiting phage resistance trade-offs.

Kunisch F, Campobasso C, Wagemans J, Yildirim S, Chan B, Schaudinn C Nat Commun. 2024; 15(1):8572.

PMID: 39362854 PMC: 11450229. DOI: 10.1038/s41467-024-52595-w.


Site-specific immobilization of the endosialidase reveals QSOX2 is a novel polysialylated protein.

Hunter C, Derksen T, Makhsous S, Doll M, Perez S, Scott N Glycobiology. 2024; 34(5).

PMID: 38489772 PMC: 11031136. DOI: 10.1093/glycob/cwae026.


Sialidase Inhibitors with Different Mechanisms.

Keil J, Rafn G, Turan I, Aljohani M, Sahebjam-Atabaki R, Sun X J Med Chem. 2022; 65(20):13574-13593.

PMID: 36252951 PMC: 9620260. DOI: 10.1021/acs.jmedchem.2c01258.


-Sialylation: a strategy used to incorporate sialic acid into oligosaccharides.

de Lederkremer R, Giorgi M, Agusti R RSC Chem Biol. 2022; 3(2):121-139.

PMID: 35360885 PMC: 8827155. DOI: 10.1039/d1cb00176k.


Crystal structure of the Propionibacterium acnes surface sialidase, a drug target for P. acnes-associated diseases.

Yu A, Volkers G, Jongkees S, Worrall L, Withers S, Strynadka N Glycobiology. 2021; 32(2):162-170.

PMID: 34792586 PMC: 8934140. DOI: 10.1093/glycob/cwab094.


References
1.
Hildebrandt H, Muhlenhoff M, Weinhold B, Gerardy-Schahn R . Dissecting polysialic acid and NCAM functions in brain development. J Neurochem. 2007; 103 Suppl 1:56-64. DOI: 10.1111/j.1471-4159.2007.04716.x. View

2.
Seidenfaden R, Krauter A, Schertzinger F, Gerardy-Schahn R, Hildebrandt H . Polysialic acid directs tumor cell growth by controlling heterophilic neural cell adhesion molecule interactions. Mol Cell Biol. 2003; 23(16):5908-18. PMC: 166353. DOI: 10.1128/MCB.23.16.5908-5918.2003. View

3.
Watson J, Indurugalla D, Cheng L, Narine A, Bennet A . The hydrolase and transferase activity of an inverting mutant sialidase using non-natural beta-sialoside substrates. Biochemistry. 2006; 45(44):13264-75. DOI: 10.1021/bi061489x. View

4.
Finne J, Leinonen M, Makela P . Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet. 1983; 2(8346):355-7. DOI: 10.1016/s0140-6736(83)90340-9. View

5.
GROSS R, Cheasty T, Rowe B . Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli. J Clin Microbiol. 1977; 6(6):548-50. PMC: 274821. DOI: 10.1128/jcm.6.6.548-550.1977. View